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We appreciate the comments and acknowledge the concerns of Dr.
Penas-Lado and colleagues regarding the etiology of transient left
ventricular apical ballooning described in our report (1). It may be
quite reasonably argued that transient dynamic left ventricular
outflow tract obstruction contributes to the pathogenesis of this
syndrome (2). Tsuchihashi et al. (3) speculated on the inclusion of
stress cardiomyopathy caused by vigorous stress (catecholamine
exposure), dynamic midventricular obstruction due to basal hyper-
contraction, and/or secondary myocardial ischemia (increased wall
tension) as an important etiological cause of this syndrome.
However, they reported that only 18% of patients (12/72 patients)
had left ventricular outflow tract obstruction and an intraventric-
ular pressure gradient 30 mm Hg during the acute phase.
We did not discuss findings of left ventricular outflow tract
obstruction in our report (1) for the following reasons. No patient
showed left ventricular outflow tract obstruction with an intraven-
tricular pressure gradient 30 mm Hg among 9 patients who
underwent pressure recording during catheter withdrawal from the
left ventricle and/or an accelerated flow in the left ventricular
outflow tract in any of the 17 patients who underwent Doppler
echocardiography during the acute phase. Moreover, little evidence
was seen of geometric predisposition (sigmoid intraventricular
septum, small left ventricular outflow tract, abnormal orientation
of a slack mitral apparatus, reduced left ventricular volume) in our
patients. However, pathological findings of the specimen obtained
from left ventricular endomyocardial biopsy during the acute phase
differed from those of myocardial ischemia (1,3,4). Moreover,
Tawarahara et al. (5) recently reported a variant type of reversible
severe left ventricular wall-motion abnormality of the basal seg-
ment with hypercontraction at the apex. It was considered that left
ventricular outflow obstruction did not contribute to the etiology
of this type of transient left ventricular abnormality. Thus, these
findings suggested that left ventricular outflow obstruction was not
a primary cause of this syndrome.
Kono et al. (6) reported that the mechanism of neurogenic
stunned myocardium in patients with subarachnoid hemorrhage
was mediated by the direct toxic effect of norepinephrine. Mann et
al. (7) demonstrated the mechanism of catecholamine-mediated
cardiac toxicity was that adrenergic stimulation leads to cyclic
AMP-mediated calcium overload of cultures of adult cardiac
muscle cells exposed to norepinephrine. Doshi et al. (8) reported
that individual necrotic muscle fibers surrounded by macrophages
and inflammatory cells and small foci of inflammatory cells
between the muscle fibers with or without the presence of necrotic
muscle fibers were observed histologically in patients with sub-
arachnoid hemorrhage. These reports suggest that the direct
toxicity of catecholamines could lead to myocyte damage.
Because none of our patients demonstrated neither significant
left ventricular outflow tract obstruction nor intraventricular pres-
sure gradient nor the evidence of geometric predisposition in our
study, left ventricular outflow obstruction was not considered a
primary cause. Therefore, we considered that this syndrome might
be caused by the direct toxicity of catecholamines.
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Are Levels of C-Reactive Protein and
Troponin T the Best Predictors of
Mortality After Acute Coronary Syndrome?
We read with great interest the article by James et al. (1) in a recent
issue of the Journal.
We were puzzled by the finding that C-reactive protein (CRP)
was related to 30-day mortality, but not to the occurrence of
myocardial infarction (MI). Indeed, as shown by Table 3, not only
was CRP unrelated to MI, but patients with a CRP value 1.84
mg/l had a paradoxically lower probability of MI than did patients
with values 1.84 mg/l (odds ratio 0.76, 95% confidence interval
0.59 to 0.98, p  0.03). We believe that these findings can be
explained by considering the potential relation (not addressed in
the report) between high CRP values and impaired left ventricular
(LV) function. Indeed, patients in the fourth CRP quartile had a
higher rate of presentation with heart failure than did patients
included in the other quartiles (p 0.001). Moreover, as shown in
Table 2 of the study, a strict relation existed between median
troponin T values and CRP (0.04, 0.08, 0.1, and 0.3 g/l being,
respectively, the troponin T values in the four CRP quartiles, p 
0.001). It is likely that high CRP values would reflect large infarcts
with impairment of LV function, an important predictor of early
death, not necessarily related to the occurrence of a subsequent MI.
Unfortunately, the investigators (1) did not include in the
multivariable analysis any index of LV function; therefore, the
independent prognostic predictivity of CRP remains questionable.
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Moreover, the researchers state that “the levels of troponin and
CRP provide important, different and complementary prognostic
information. . . . The combination of both markers allows the best
prediction of mortality.” We do not share such enthusiastic
comment. Table 4 in the James et al. (1) study (“Mortality at 30
Days in Relation to Quartiles of Troponin T and CRP”) shows
that patients with the highest values of troponin T (0.47 g/l)
and CRP (9.62 mg/l) had a 9.1% death rate, which is not very
different, on clinical grounds, from the 7.4% death rate of all
patients included in the highest troponin T quartile (the clinical
relevance of the 3.6% mortality in the first CRP quartile being
affected by the small number of patients in that subgroup, n 
250). In contrast, in the lowest troponin T quartile (0.01 g/l),
the death rate was 1.4% in patients with the highest CRP values
(9.62 mg/l), not dissimilar from the 1.1% death rate of all
patients with0.01 g/l troponin levels. From these data it seems
that CRP does not provide any additional important prognostic
information to the simple knowledge of troponin T values.
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We appreciate the interest of Drs. De Servi and Mazzone in our
recently published study (1). The relation between C-reactive
protein (CRP) elevation and subsequent mortality in our study is
very consistent with the results of numerous previous studies
(2–4). In contrast to earlier trials, our study from the GUSTO IV
investigation included a sufficiently large number of patients to
allow the evaluation of subsequent death and myocardial infarction
(MI) separately. It is correct that patients with a CRP level above
1.84 mg/l, paradoxically, had a lower probability of MI at 30 days’
follow-up than did patients with a CRP level 1.84 mg/l. This
statistical significance is, however, dependent on the chosen cutoff
for CRP. A more correct interpretation would be that no relation
exists between levels of CRP and the incidence of MI at 30 days’
follow-up in this selected patient population, as several previous
studies have suggested (3,4).
Levels of CRP and troponin T are correlated (Spearman rank
correlation coefficient 0.24, p  0.001), and a large part of the
inflammatory response seems to be a result of myocardial necrosis
(5). Interestingly, in a multiple linear regression analysis, a history
of MI (10 days before admission), heart failure, levels of
troponin T, and diabetes mellitus were factors with the strongest
independent relation to admission levels of CRP (data not shown).
Thus, CRP elevation at admission in patients with acute coronary
syndromes may be explained by different processes, among them
myocardial remodeling and fibrosis (6) and not solely by the acute
myocardial damage.
The 9.1% mortality at 30 days for patients with troponin T in
the top quartile (0.47 g/l) together with CRP in the top
quartile (9.62 mg/l) may not seem to be extremely different from
the 7.4% mortality for all patients with troponin T above 0.47 g/l
(regardless of CRP levels). Still, the addition of CRP elevation
resulted in a 1.7% absolute increase in 30-day mortality with an
independent contribution. For long-term mortality, CRP provided
an even better prediction, with 17.8% mortality for patients with
CRP and troponin T in the top quartiles (Table 1) as compared to
13.3% for all patients with troponin T in the top quartile. In a
multiple regression analysis, CRP was an independent predictor of
one-year mortality after correction for a large number of significant
predictors, including a history of heart failure on admission as well
as heart rate and elevated levels of troponin T and N-terminal pro
brain natriuretic peptide (7). Hence, CRP provides an independent
prediction on long-term mortality beyond a history of, and clinical
signs of, heart failure as well as biochemical markers indicating
myocardial damage and dysfunction. The mechanisms responsible
for this increased mortality needs to be further investigated (7).
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Table 1. Mortality at One Year in Relation to Quartiles of Troponin T and CRP
CRP, mg/l
Troponin T (g/l)
p
Value*<0.01 0.01–0.12 0.12–0.47 >0.47
1.84 1.7 (11) 5.8 (28) 7.7 (30) 8.8 (22)  0.001
1.84–3.96 5.1 (27) 5.6 (25) 5.1 (23) 11.6 (41)  0.001
3.96–9.62 3.2 (14) 7.7 (30) 8.4 (40) 10.2 (48)  0.001
9.62 6.1 (22) 13.8 (43) 14.1 (60) 17.8 (121)  0.001
p value* 0.01*  0.001*  0.001*  0.001*
Figures are shown as percentages; number of patients are shown in parentheses. *Chi-square linear-by-linear association.
CRP  C-reactive protein.
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